克里斯普尔屏幕定义了癌细胞自主免疫逃避的统一标志
Anne Huber1, Tirta M Djajawi1, Isela Sarahi Rivera2
1Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.
Cell reports
|December 19, 2025
概括
癌细胞有自主机制逃避免疫疗法,阻碍了患者的益处. 了解这些癌症特异性途径是提高癌症治疗效率的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 癌症免疫疗法已经彻底改变了治疗方法,但它只对一小部分患者有益.
- 免疫逃脱是一个重大挑战,癌细胞自主机制发挥着关键作用.
- 以前的策略集中在免疫细胞和瘤微环境上,忽视了癌细胞内在因素.
研究的目的:
- 阐明癌细胞免疫逃避的自主机制.
- 绘制出瘤逃脱 CD8+ T 细胞介导压力的途径.
- 确定新型治疗策略的目标,以提高免疫疗法疗效.
主要方法:
- 使用高通量功能基因组学,包括基于CRISPR的体外和体内查.
- 分析癌细胞基因组,转录组和表观组.
- 研究对细胞因子信号传递的脱敏性 (例如,干扰素-,瘤亡因子).
主要成果:
- 识别了癌细胞的自主程序,驱动免疫逃生.
- 已证明抗原呈现受损,并对像PD-L1这样的抑制性配体进行上调.
- 揭示了癌细胞内的免疫性通路的表观遗传沉默.
结论:
- 癌细胞自主机制是免疫疗法耐药性的关键驱动因素.
- 了解这些内在的癌症途径对于开发下一代免疫疗法至关重要.
- 针对这些机制可以扩大免疫治疗对各种癌症的影响.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
The Antiviral System of Bacteria and Archaea: CRISPR
596
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
596
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


